Compass Pathways, the startup focusing on using psilocybin to treat mental health conditions, has raised $80M in Series B funding from investors that include Founders Fund, Perceptive Advisors, Camden Partners, Able Partners, Solus Capital, ATAI Life Sciences, McQuade Center for Strategic Research and Development, and Skyviews Life Science. Founded by Ekaterina Malievskaia, George Goldsmith, and Lars Christian Wilde in 2016, Compass Pathways has now raised a total of $116.2M in reported equity funding.
The TechWatch Media Group audience is driving progress and innovation on a global scale. With its regional media properties (London, NYC, LA, Paris, Boston), TechWatch Media Group is the highway for technology and entrepreneurship. There are a number of options to reach this audience of the world’s most innovative organizations and startups at scale including having prominent brand placement in a high-visibility piece like this, which will be read by the vast majority of key influencers in the London business community and beyond. Find out more here.
